In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

Applied Genetic Technologies Corp.. Trade Record

NASDAQ:AGTC Applied Genetic Technologies Corp. stock gains 7.64% Exit Jan 16, 2018 a Trade Record by priceseries

Trade Chart
Trade Chart AGTC Jan 2, 2018, priceSeries
About Applied Genetic Technologies Corp.

Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops genetic therapies to treat patients with inherited diseases. Its lead products consist of four ophthalmology development programs across three targets, including X linked retinoschisis (XLRS) that is in a Phase I/II clinical trials for the treatment of an inherited retinal disease; X-linked retinitis pigmentosa (XLRP), which is enrolling patients in a Phase I/II clinical trials; and achromatopsia (ACHM) that is enrolling patients in a Phase I/II clinical trials. Applied Genetic Technologies Corporation has collaboration agreements with Biogen MA, Inc.; 4D Molecular Therapeutics; and Synpromics Limited. The company was founded in 1999 and is headquartered in Alachua, Florida.

Trade Information
Trade Type
LONG
ReliabilityScore™
98.08
Entry Date
Jan 2, 2018
Entry Price
3.75
Sell Date
Jan 16, 2018
Sell Price
4.04
Net Gain
7.64%
Hold Time
9 Trading Days